Roche Media ١٩ مارس ٢٠٢٦ Genentech shreds RIPK1 inhibitor from pipeline after early ph. 2 failure - Fierce Biotech
Roche Media ١٨ مارس ٢٠٢٦ Senegal explores partnership with Roche to strengthen cancer care and health system capacity - Tech Review Africa
Roche Media ١٠ مارس ٢٠٢٦ Lilly pledges $500M to South Korea biopharma industry, following Roche’s lead - Fierce Biotech
Roche Media ٩ مارس ٢٠٢٦ Roche’s oral SERD flunks phase 3 trial in 1st-line breast cancer, raising questions of mechanism's limits - Fierce Biotech
Roche Media ٩ مارس ٢٠٢٦ Roche’s prized breast cancer pill fails closely watched study - BioPharma Dive
Roche Media ٩ مارس ٢٠٢٦ ZAWYA-PRESSR: Ministry of Health and Population and Roche Diagnostics sign MoU to advance digital pathology in Egypt - TradingView
Roche Media ٦ مارس ٢٠٢٦ Roche, Zealand tout the tolerability of their amylin obesity drug - TechTarget
Roche Media ٦ مارس ٢٠٢٦ Roche’s petrelintide shows promise in Phase II obesity trial - The Pharma Letter
Roche Media ٥ مارس ٢٠٢٦ Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug - Fierce Biotech
Roche Media ٤ مارس ٢٠٢٦ Roche announces $481m investment in South Korean biotech sector - Investment Monitor
Roche Media ٤ مارس ٢٠٢٦ Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem' - Fierce Biotech
Roche Media ٤ مارس ٢٠٢٦ Roche to invest $478 million in Korea clinical trials over 5 years - koreabiomed.com
Roche Media ٤ مارس ٢٠٢٦ Roche to invest $481 mn in South Korea clinical trials, biotech partnerships - The Korea Economic Daily Global Edition
Roche Media ٢٤ فبراير ٢٠٢٦ Roche halts development of satralizumab for DMD bone health - Muscular Dystrophy News